Background: It is common for patients with cancer to present with delirium during cancer treatment due to various causes, such as infection, electrolyte abnormalities, medications, and brain metastasis. Furthermore, delirium may also occur when a patient with cancer develops Trousseau syndrome. Delirium due to Trousseau syndrome in a cancer patient with a history of repeated delirium might be mistaken for previous episodes, which could lead to overlooking a stroke.
Case description: A male aged 90 years with gallbladder cancer was admitted to the hospital. During hospitalization, he experienced recurrent episodes of cholangitis and fever, accompanied by delirium. His inflammatory response decreased, and his fever resolved following antibiotic treatment. After recovery, he experienced a loss of appetite, and olanzapine (2.5 mg/day) was started on Day 17 of hospitalization. However, early on Day 21, he suddenly became restless, moaned loudly, and exhibited signs of delirium. Initially, delirium due to olanzapine or reinfection was suspected. However, a new stroke was suspected because of speech impairment as well as the sudden onset of delirium. Head magnetic resonance imaging revealed a fresh stroke in the right basal ganglia, which was identified as the cause of the delirium.
Conclusions: Patients with cancer are more prone to developing stroke due to the hypercoagulable state associated with malignancy. Even in the absence of obvious neurological signs, such as hemiplegia, the possibility of Trousseau syndrome needs to be considered when a patient presents with atypical or sudden-onset delirium.
扫码关注我们
求助内容:
应助结果提醒方式:
